Immunohistochemistry analyses of LAG-3 expression across different tumor types and co-expression with PD-1.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e15086
Abstract: e15086Background: Concomitant blockade of LAG-3 and PD-1 has been shown to restore T-cell activation and enhance anti-tumor immunity in preclinical models. Clinical trials evaluating anti-LAG-3/ant... read more here.
Keywords: immunohistochemistry analyses; tumor; analyses lag; expression ... See more keywords